Skip to main content

Palo Alto Investors LP

Position in NVCR — NovoCure Ltd

CIK 1306923 PALO ALTO, CA

Position in NVCR

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$13,956,785
-$2,838,819 QoQ
Shares Held
1,280,439
-1.4% QoQ
Ownership
1.11%
of shares outstanding
% of Portfolio
2.17%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2023
13 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in NVCR Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Mar 31, 2026

Palo Alto Investors LP holds $17,103,135 across 3 Medical Devices names. NVCR ranks #1 (81.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NVCR
NovoCure Ltd
This page
1,280,439 $13,956,785

All Filings in NVCR

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $13,956,785 1,280,439
2025-12-31 $16,795,604 1,298,964
2025-09-30 $16,229,574 1,256,159
2025-06-30 $17,130,648 962,396
2025-03-31 $17,856,727 1,002,061
2024-12-31 $24,262,891 814,191
2024-09-30 $9,277,030 593,540
2024-06-30 $9,625,484 561,908
2024-03-31 $8,782,622 561,908
2023-12-31 $8,389,286 561,908
2023-09-30 $10,663,441 660,275
2023-06-30 $23,991,897 578,118
2023-03-31 $1,971,990 32,790